Picture of Genedrive logo

GDR Genedrive Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Genedrive, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-5.48-5.62-5.22-5.31-5.43
Depreciation
Non-Cash Items-0.0010.0380.0960.0590.13
Other Non-Cash Items
Changes in Working Capital0.0850.7331.071.240.085
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-5.15-4.59-3.81-3.77-5.14
Capital Expenditures-0.104-0.062-0.052-0.029-0.023
Purchase of Fixed Assets
Other Investing Cash Flow Items0.1050.0910.0440.030.043
Other Investing Cash Flow
Cash from Investing Activities0.0010.029-0.0080.0010.02
Financing Cash Flow Items2.020.586-0.089
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.4566.581.826.361.12
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5.642.02-1.992.59-4.01